Memory consolidation is the process by which relevant information is selected and transferred from a shortterm, fragile state, into a stable, longer term domain from which it can be recalled. Effective memory underpins our ability to carry out everyday activities. When memory consolidation fails, such as in Alzheimer's disease, the consequences can be devastating. Understanding the neurobiology of memory will help develop treatments for patients with memory loss. Here we describe the myriad processes involved in memory consolidation, including cholinergic and dopaminergic neurotransmission predominantly in hippocampal networks. We discuss established therapies as well as potential novel strategies for boosting cognition. Future approaches to enhancement of memory consolidation include not only pharmacological and neurosurgical treatments, but also lifestyle interventions -for example, modifications to sleep, exercise and diet.
Introduction
Memory consolidation is the process by which information is transferred from the fragile, readily-disposable state of short- 
Who is a ected by memory consolidation de cits?
Prominent memory impairment is a feature of AD. AD is a neurodegenerative disease affecting more than 35 million people worldwide costing in excess of $600 billion US per year.
Prevalence of AD dramatically increases with age, affecting around 20% of those aged 85 years [1] . Neuropathological staging and sensitive neuroimaging techniques tell us that the hippocampus is affected in the very earliest stages of AD [2, 3] . Given the role of the hippocampus in memory consolidation, it is therefore no surprise that AD is often characterised by decline in memory, although other cognitive domains are usually affected by the time a diagnosis is made [4] . In other dementias, including dementia with Lewy bodies, frontotemporal dementia and vascular dementia, memory is also often affected, but this is less consistently an early finding.
Although less critical socio-economically, other diseases in which memory consolidation is affected can be equally devastating to the individual. The hippocampus can be affected irreversibly in viral encephalitis and is a particular target for antibodies including voltage-gated potassium channel antibodies and other paraneoplastic antibodies producing amnesia as part of a syndrome of limbic encephalitis [5] . In addition, thiamine de ciency, recurrent seizures and hippocampal sclerosis can all also result in variable memory impairment. Many of these conditions can be treated, but often result in permanent memory consolidation impairment which would be potentially amenable to targeted therapy.
There is also evidence that memory consolidation is affected by normal ageing [6] and certain younger people (e.g. students,
scientists, doctors, news reporters) might bene t from enhanced memory consolidation, raising the controversial possibility of cognitive enhancement in the neurologically healthy. factor (BDNF) and these will also be discussed along with their potential for modification.
Mechanisms underlying memory consolidation

Acetylcholine
ACh is an obvious starting point for a discussion on cognitive enhancement, as cholinesterase inhibitors -which act by increasing the levels of ACh -are the major licensed drugs for memory enhancement in AD [17] . The rationale for using these drugs was established along with the cholinergic hypothesis of memory dysfunction rather than targeting specific memory deficits.
If we focus on the potential for targeted enhancement of memory consolidation in patients, the muscarinic subtypes are of particular importance [22] . Of subtypes M1-5, M1 is of specific interest, especially when we consider the fact that these receptors are expressed in brain areas implicated in the twostage theory of memory , the hippocampus and neocortex [23] . M1-selective antagonists impair long-term, but not short-term memory [24, 25] .
In addition, a study looking at M1-selective knockout animals found no effect on early performance in spatial learning tasks; once the animal was tested after a delay, however, deficits became apparent in the M1-knockout but not the wild type animals, suggesting a critical role for the M1 receptor specifically in long-term consolidation, but not short-term memory [26] . Human work on M1 agonism and memory consolidation during sleep has shown effects on sleep, but no benefit to cognition [27, 28] . However, newer more specific M1
agonists are now available, and much of the previous work looked at healthy young controls There are small trials underway of deep brain stimulation of cholinergic networks in AD.
Putative targets include the nucleus basalis of Meynert (brain stem cholinergic nucleus) [30] and fornix [31] . Further preliminary data in 
The role of dopamine and other monoamines in memory consolidation
How does the role of dopamine in memory consolidation differ from that of ACh? Animal work has suggested that dopamine is more involved in late memory consolidation (i.e. over hours) than early memory formation [33] .
In addition, recent human data has suggested that dopamine might be important for longterm memory consolidation rather than early memory retention [34, 35] . One study in patients with Parkinson's disease suggested that removal of exogenous dopamine impaired memory consolidation over one hour, but not over 20 minutes [35] .
As well as being critical for longer term memory consolidation, dopamine may have a role in information selection prior to storage; potentiating memory traces for objects that are novel, rewarding or aversive and therefore, ensuring more biologically relevant information is stored e.g. [36] . Dopaminergic connections to the hippocampus come from the ventral tegmental area (VTA) and substantia nigra, interconnecting with brain regions processing the valence of incoming information. Regarding negative valence in particular, a dopamine receptor-dependent network has been suggested in rats, promoting the retention of information about aversive stimuli, presumably so danger can be avoided [37] . Therefore, dopamine appears to have a speci c role in late memory consolidation and enhancing certain memories traces according to context.
Methylphenidate and moda nil act by
increasing levels of dopamine and, to a lesser degree, noradrenaline, and can be prescribed for attention de cit hyperactivity disorder (ADHD) [38] [39] [40] . In addition, both are gaining recognition as cognitive enhancers [41, 42] .
Indeed, methylphenidate has been found to increase cognitive performance, including speci cally memory consolidation, in healthy people without ADHD [43] . There is increased activity within the prefrontal cortex after taking methylphenidate [44] leaving open the possibility that prefrontal networks mediate part of the cognitive enhancement effect via a boost in alertness or processing capacity rather than a speci c enhancement of memory circuits. Modafinil rescues memory consolidation in sleep deprived animals [45] , and enhances memory consolidation in healthy humans [46] . However, mofadinil also acts via orexins [47] and the effects of the drug may be attributed in part by enhancement of wakefulness (and therefore attention) rather than directly exerting an effect on memoryhence its prescription in narcolepsy.
Amphetamine has been found to improve memory consolidation in rats [48, 49] . It has also been found to improve memory encoding [50] and consolidation in humans [51] and has therapeutic potential to rectify memory de cits in patients with multiple sclerosis It is also interesting to note that administration of both moda nil and amphetamine results in increased number of ripples during subsequent SWS [58] . This has been thus far attributed to 'rebound' of ripples following the increased wakefulness caused by these stimulant drugs. However, it may well be worth further investigating these effects to see if increase in ripples has any functional signi cance matching to the purported cognitive bene ts of these drugs, particularly as increased ripple number is linked to increased consolidation.
Brain-derived neurotropic factor (BDNF)
Of particular interest is that increases in BDNF link many of the non-invasive interventions described later in this review -most notably, BDNF is of particular importance for AD, as levels have been found to be decreased in AD patients, and exogenously increasing BDNF levels has potent benefits for memory. Its exogenous infusion has been found to induce neurogenesis in rats [61] , and in rodent models of AD prevents neuronal loss, reverses loss of synapses, and restores memory function.
There are similar bene ts in aged rats and [65] , and has also been found to increase SWS [66] -making it a promising therapeutic target. However, given that its effects on memory are thus far mixed [65, 67] and its effect on sleep EEG activity varies greatly between genders [68] , further, more detailed investigation is certainly warranted.
Another strategy is to target SWS and slow oscillations in order to evoke some bene t to memory consolidation. Indeed, this does seem extremely promising -one way to do this has been by using transcranial magnetic stimulation (TMS) allowing for a more focussed intervention than can be afforded by pharmacological methods. This has been successful in increasing slow oscillations in rodents and humans [69] as well as eliciting corresponding enhancements in memory consolidation [70] . Another intriguing method being explored is the induction of slow oscillations by using auditory cues. Here, the auditory stimulation is played during SWS, using low frequency range-auditory cues to augment the oscillatory activity of the < 1 Hz slow oscillations. This has, indeed, been found to increase the amount of slow-oscillations, but results were sometimes mixed [71] . More recently, however, a study in healthy humans [72] used online monitoring of slow oscillations in order to administer the auditory cue in phase with the ongoing slow wave activity. Playing such cues produced reliable increases in slow oscillations, and a corresponding increase in memory consolidation, above that which was found in unaltered sleep. This is a very appealing nding, given that it indicates very promising outcomes can be attained from such a non-invasive mechanism, without any pharmacological or neurosurgical intervention, and without the side-effects of TMS. These bene ts were found in young healthy human subjects, but the merits are yet to be assessed in elderly or AD populations.
Exercise
There are a plethora of studies clearly illustrating that physical activity improves hippocampal function. Importantly, this improvement is not solely due to temporarily improved blood ow to the brain, but it has a robust neurophysiological basis, in the promotion of neurogenesis within the hippocampus (e.g., [73, 74] ). Neurogenesis is also accompanied by an increased neurite outgrowth, hence increased connectivity. Moreover, exercise also induces brain angiogenesis [75] , thereby promoting a positive cycle for brain function.
Hippocampal volume is also seen to increase in human subjects with physical activity -for instance, level of physical tness has been linked with a higher hippocampal volume in children [76] . A multitude of studies demonstrate that this exercise-induced change also has its functional bene ts, such as improved memory in animals [77] and healthy young human participants [78] .
Ageing is accompanied by a decrease in neurogenesis in animals [79, 80] , and imaging in humans demonstrates that hippocampal volume is decreased with age [81] . Exercise, however, can ameliorate this -it improves spatial memory that normally deteriorates with age [77] , and there is larger hippocampal volume in older adults with higher fitness [76] . This suggests that despite there being an age-related decline, there exists nevertheless a window of plasticity that can be harnessed through the beneficial effects of physical training.
Exercise is also a promising therapeutic aid.
When looking at a mouse-models of AD (3xTg), aerobic exercise was found to decrease the symptoms and development of dementia [82] -moreover, while neurogenesis is normally impaired in this mouse model, it was actually restored to the extent of being comparable with wildtype control animals, after exercise who are at risk of AD [85] . Furthermore, one intriguing study suggests speci c types of physical activity can differentially affect individual facets of memory; in MCI patients, verbal memory was improved by aerobic exercise, but spatial memory was improved by both aerobic and resistance training [84] .
Animal work suggests a putative mechanism for these differential effects. In rats, aerobic exercise training increased insulin-like growth factor 2 (IGF-2), while resistance training exercised rats were found to have higher levels of BDNF [86] . Along with BDNF, IGF-2 may be an important factor in memory processes [87] .
Therefore, the relationship between memory consolidation and physical activity is now well-established, and provides an enticing opportunity for memory enhancement through exercise, for both healthy and pathological populations.
Diet
Glucose
Glucose appears to be especially important for hippocampal-dependent memory [90, 91] , and for demanding tasks [92] [93] [94] . After awakening, blood glucose levels in the brain are relatively low [88] , and improvements in working memory have been demonstrated upon glucose administration -regardless of whether blood glucose levels were depleted upon time of administration [89] . Moreover, this increase in blood glucose is dissociable from bene ts in attention alone, as memory performance bene ts both when glucose is administered before or after learning, and attention would only be a relevant factor at the point of learning rather than afterwards.
Interestingly, the elderly population seem to derive more bene t in memory function from increasing glucose compared to healthy young participants [90] . The primary site of action or effects of glucose has been proposed to the hippocampus, where it may be involved in ACh synthesis, which in itself is a prominent player 
Calorie Restriction
Calorie restriction (CR) is a dietary regime involving reducing calorie intake by around 10 -30%. There are various methods by which this restriction can be achieved -by reducing daily food intake, by alternate day fasting, or by intermittent fasting [95] . Although it may seem somewhat counterintuitive at rst glance, inhibiting intake in this way actually has profound, well-documented beneficial results. It is most well-known in the literature as having longevity-enhancing effects, something which has been demonstrated in a wide range of organisms [96, 97] , and it also acts to delay age-related diseases, and a combination of both these effects have been demonstrated in rodents [98] and rhesus monkeys [99] . CR has been found to bene cially alter the expression of synaptic proteins that would normally be reduced by ageing [100] and ameliorates the effects of age-related cognitive decline in rodents by increasing levels of BDNF. Even aged rats that underwent late-onset CR had a degree of rescue of function [101] . CR protects against neurodegeneration, increases neurogenesis and memory performance, and decreases amyloid beta (Aβ) plaques in animal models of AD [102, 103] . 
Polyunsaturated fatty acids
Omega-3 fatty acids are emerging as a crucial factor for neuronal health and function.
Observed at the mechanistic level, the importance of omega-3 fatty acids becomes readily apparent -they are central to the development and maintenance of neurones and synaptic function [108] . It follows that rats with low omega-3 intake had decreased neuronal plasticity [109] , while animals given omega-3 within their diet have increased BDNF expression within the hippocampus and neocortex [110] , which are key sites for memory
consolidation.
An omega-3 fatty acid enriched diet also has therapeutic potential for AD -when given to the 3xTg mouse model of AD, the loss of neurones within the entorhinal cortex was reduced, and memory de cit development was delayed compared to controls [111] . Administration of omega-3 fatty acids in another mouse model (Tg2576) allowed for increased synaptic integrity, and again, manifested with a behavioural improvement -memory performance in the Morris water maze was increased.
Conclusion
There is a range of non-invasive, easy to 
